Malignant Paraganglioma of the Retroperitoneum with Lung Metastases: A 13-year Survivor After Radical Surgery  by Matsui, Hideo et al.
ASIAN JOURNAL OF SURGERY VOL 30 • NO 1 • JANUARY 2007 75
Case Report 
Malignant Paraganglioma of the Retroperitoneum
with Lung Metastases: A 13-year Survivor 
After Radical Surgery
Hideo Matsui,1,2 Shunji Ikeuchi,3 Noboru Onoda4 and Yutaka Tsutsumi,5 1Research Institute for Life Extension
and 2Department of Surgery, Eiju General Hospital, 3Department of Surgery, The National Tokyo Medical Center,
Tokyo, 4Department of Pathology, Yamato Municipal Hospital, Kanagawa, and 5Department of Pathology, 
Fujita Health University School of Medicine, Aichi, Japan.
We present a 23-year-old patient with extra-adrenal retroperitoneal paraganglioma with lung metastases
who was successfully treated by complete removal of the tumour. Lung metastases were the first manifes-
tation of the disease, and an abdominal computed tomography scan showed a large mass in the retroperi-
toneum with marked contrast enhancement. Angiography demonstrated a hypervascular mass with many
feeding arteries, but vascular invasion was not apparent. The retroperitoneal tumour was resected completely
followed by resection of lung metastases after 1 month of observation. The patient was disease free for
13 years after this radical surgery. The survival rate in patients with retroperitoneal paraganglioma with
lung metastasis is low, and this case represents the longest surviving period reported in the literature.
These tumours are usually large and located in the para-aortic region, and hence resection is sometimes
challenging. We believe that a complete and meticulous surgical procedure is a prerequisite for long survival
from this rare disease. [Asian J Surg 2007;30(1):75–9]
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Introduction
Paragangliomas (PGs) are rare tumours originally described
as structural characteristic of neural crest origin. They are
found in tissues such as the adrenal medulla, carotid bod-
ies, organ of Zuckerkandl, and paraganglia of the sympa-
thetic and parasympathetic neurons. PGs occur most
commonly in head and neck lesions.1 Much less frequently,
they are found in the retroperitoneum and it has been
estimated that as much as 10% arise outside the adrenal
gland.2 Distant metastasis to bones, lymph nodes and
lungs has been reported as a unique feature of the
metastatic spread of PGs.3 Although a recent long-term
follow-up study showed a relatively indolent clinical
course,3–6 the therapeutic modalities for patients with
metastatic PGs, i.e. malignant PGs, are still controversial.
Moreover, due to the rarity of retroperitoneal PGs,4,7 the
clinical course and the treatment of choice are unclear.
We present a patient with extra-adrenal retroperitoneal
PG with lung metastases who was successfully treated by
radical surgery including at the metastatic site. The patient
has survived for 13 years without any sign of recurrence.
Complete surgical removal of a tumour as well as metas-
tases offers the only chance for cure, because no other
therapeutic modality has been shown to provide long-
term survival.
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Case report
A 23-year-old man was referred to The National Tokyo
Medical Center (NTMC) because of abnormal shadows on
chest X-rays. He had no remarkable symptoms. On admis-
sion, his blood pressure was 113/70 mmHg. Physical
examination revealed a fixed and hard mass with slight
tenderness in the left upper quadrant, protruding 4 cm
below the costal margin. Laboratory data on admission
were within normal ranges, including serum tumour
markers (CEA, CA19-9) and catecholamines. Chest X-ray
showed two round masses, 0.5 and 1.5 cm in diameter, in
the middle lobe of the right lung (Figure 1). Computed
tomography (CT) showed a low-density mass, 10 cm in
diameter, with uneven contrast enhancement in the
retroperitoneum dorsal to the pancreas and the spleen,
and ventral to the left kidney and the abdominal aorta
(Figure 2). No lymph node swelling and distant metastasis
were detected except for the lesion in the right lung. On
magnetic resonance imaging (MRI), the signal intensity
of the primary tumour was higher than that of muscles
on T1-weighted images (Figure 3), and remarkably higher
on T2-weighted images; moreover, the tumour contained
many flow voids. Selective angiography of the coeliac artery
showed a hypervascular mass supplied by several feeding
arteries originating from the splenic artery and the inferior
phrenic artery (Figure 4A). In contrast, the right half of
the mass was supplied mainly by the superior mesenteric
artery (Figure 4B). A tumour stain appeared in the early
arterial phase and lasted into the later phase as a dense
capillary stain. Faint opacification of draining veins was
also observed, and vascular involvement was not apparent.
[97Ga] citrate and [131I] metaiodobenzylguanidine (MIBG)
scans showed no abnormal accumulation.
Despite the metastases in the right lung, we chose sur-
gical resection of the primary lesion for the initial treat-
ment of this patient, which was performed in August
1992. The stomach, transverse colon, pancreas and spleen
were found to be displaced ventromedially by a mass in
the retroperitoneum. There was no significant adhesion
to the ventral surface of the tumour, on which numerous
tortuous vessels were observed. The hilum of the left kidney
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Figure 1. Chest X-ray shows two round masses (arrows), 0.5 and
1.5 cm in diameter, in the middle lobe of the right lung.
Figure 2. Computed tomography shows a low-density mass in the
retroperitoneum dorsal to the pancreas and ventral to the left
kidney. The tumour apparently affects the abdominal aorta.
Figure 3. On magnetic resonance imaging, the signal intensity 
of the retroperitoneal tumour is higher than that of muscles on
T1-weighted images, and the tumour contains many flow voids.
was tightly adherent to the left border of the tumour, and
the left renal vein was buried in the ventral surface of the
tumour. The tumour appeared to be separate from the
left adrenal gland. It was difficult to identify the left renal
artery even though we mobilized the left kidney from the
retroperitoneum. Therefore, we decided to perform a
combined resection of the left kidney. Resection of the
tumour from the abdominal aorta was extremely diffi-
cult. We excised many fine feeding arteries originating
from the abdominal aorta, sparing the coeliac artery and
the superior mesenteric artery. We successfully removed
the tumour without causing it to rupture.
The resected tumour (12.5 × 11.0 × 6.8 cm) was solid,
with many tortuous vessels on its surface (Figure 5). The
cut surface of the formalin-fixed tumour appeared browny-
red, and vessels and fibrous septa were widespread.
Macroscopically, tumour invasion into the kidney and the
adrenal gland was not apparent, but renal vessels appeared
to be involved in the tumour. Histologically, the tumour
was an alveolar-like structure with many vascular septa
(Figure 6). Tumour cells contained fine eosinophilic gran-
ules; cell mitosis and nuclear atypia were infrequent.
Immunohistochemical investigations were performed 
for α-smooth-muscle actin, S-100 protein and neuron-
specific enolase, revealing only positive immunoreactivity
to S-100 protein in the sustentacular cells. Electron micros-
copy demonstrated many mitochondria in the cytoplasm
of the tumour cells, but no secretory granules were
observed. These findings led to a histological diagnosis of
nonchromaffin PG of the retroperitoneum.
The postoperative course was uneventful, and the
patient was re-evaluated for the metastatic lesion. Lung
metastases were unchanged and no other metastatic
lesion was evident. The patient underwent a second opera-
tion for lung metastases 1 month after the first operation.
A middle lobectomy of the right lung was successful, and
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Figure 4. (A) Selective angiography of the coeliac artery shows a hypervascular mass supplied by several feeding arteries originating from
the splenic artery and the inferior phrenic artery. (B) The right half of the mass is supplied mainly by the inferior mesenteric artery.
Figure 5. Combined resection of the left kidney was performed.
The resected tumour (12.5 × 11.0 × 6.8 cm) is solid, with many
tortuous vessels on its surface.
Figure 6. Tumour was an alveolar-like structure with many vas-
cular septa. Mitotic structures and nuclear atypia are infrequent.
Haematoxylin and eosin stain, reduced from 300×.
the patient was discharged 2 weeks later. The pathological
diagnosis was metastatic PG. Thereafter, he received 
biannual follow-up evaluation at the NTMC. Thirteen
years after the operation, the patient was alive without
any sign of recurrence.
Discussion
Lung metastases were the first manifestation of the disease
in the present case, and subsequent examination revealed
a retroperitoneal tumour that was diagnosed histologically
as PG. CT showed a large mass with marked contrast
enhancement originating from the retroperitoneum and
affecting the abdominal aorta. Usually, the tumours are
closely related to the abdominal aorta, following the dis-
tribution of the aorticosympathetic chain.8 Retrospectively,
MRI findings were rather typical for PGs: a mass with
high signal intensity and containing many flow voids.3
Furthermore, angiography demonstrated some unique
features of the tumour:9,10 hypervascularity with many
feeding arteries, early venous filling and prolonged tumour
staining. In this case, angiography was very helpful in
revealing the vascular supply as well as the extent of the
invasion. Although an MIBG scan did not delineate the
tumour in this case, in small tumours not seen on CT
images, it may be helpful in determining whether the PGs
are functional or nonfunctional.4 The preoperative diag-
nosis of retroperitoneal PGs is usually difficult if they are
not functional. Histologically, the present case showed a
typical alveolar appearance11 without any malignant cel-
lular features, even though the patient had lung metas-
tases. It is generally considered that malignant potential,
local invasiveness and distant metastasis are not corre-
lated with the histological appearance of the tumour.12
Immunohistochemically, the origin of the tumour was
neurogenic, since sustentacular cells surrounding tumour
cells were positive for S-100 protein. Electron microscopic
examination failed to demonstrate any secretory granules
in the cytoplasm of tumour cells. Instead, many mitochon-
dria in the tumour cells were found, as also described by
Oguma et al.9
Retroperitoneal PGs are extremely rare, and few reports
have described the natural history of the tumour. Sclafani
et al reviewed 22 patients with extra-adrenal retroperi-
toneal PG.4 The male-to-female ratio was close to 1, and the
median age was 42 years. Most patients complained of pain
or the presence of a mass, and eight (36%) patients had
functional tumours. They found that 11 of the 22 PGs
(50%) metastasized to distant organs such as bone, liver,
peritoneum, pelvis, ovaries, cervical lymph nodes and lungs.
Two (18%) of the 11 patients had their first metastases
more than 7 years after diagnosis, and hence a longer fol-
low-up is needed in this disease. The malignancy rate of 50%
reported by Sclafani et al4 is higher than that in all other
previous studies (range, 22–44%). The malignancy rate of
PG of the adrenal gland is about 10%,2 indicating that
extra-adrenal retroperitoneal PGs tend to metastasize
more frequently. Patients with retroperitoneal PGs have 
a long-term risk for recurrence;4 the disease-free 5- and
10-year survival rates are only 52% and 35%, respectively.
The 5-year disease-free survival rate was 19% for unresected
tumours and 75% for those that were completely resected.4
On the other hand, the 5-year survival rate of patients with
metastatic disease dropped to 36%, with a median survival
of 34 months.4 Mikhail et al reviewed 13 cases of malig-
nant retroperitoneal PGs.12 The average age was 39 years
(range, 12–68 years), predominantly male (69%). The most
common sites of metastasis were bone, liver and lungs. The
median survival of the patients with retroperitoneal PG
with lung metastasis was 2 years (range, 7 months–11
years). The present case with lung metastases therefore
represents the longest surviving period reported in the lit-
erature. Chemotherapy or radiotherapy may be used for
palliation of symptoms related to recurrent or metastatic
tumours,4–6,13 but their benefit in terms of prolongation
of survival is yet to be elucidated.
The tumour resection required great care not to rup-
ture the tumour and to ligate the substantial vascular
supply. Resection is often challenging, as highly vascular
tumours are large and located near vital blood vessels
such as the aorta, vena cava, and renal and mesenteric ves-
sels.4,8,14 A combined resection is inevitable when tumour
invasion into the neighbouring organ is suspected.1,7,15,16
In the present case, we suspected tumour invasion into
the kidney, ureter and the renal vessels. Fortunately, how-
ever, histological invasion into the neighbouring organs
and lymph node metastasis were not apparent. It can be
problematic deciding on a combined resection during
operation. Since local lymph node involvement was
reported in malignant retroperitoneal PG,12,17 en bloc
resection is recommended. Because the tumour appeared
indolent and a single metastatic site was operable, we per-
formed a metastasectomy—resection of the middle lobe
of the right lung after 1 month of observation—that
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resulted in the complete removal of the tumour. We
believe that complete and meticulous resection of the
tumour was a prerequisite for the favourable outcome of
this patient, although further follow-up will be needed to
demonstrate a complete remission of the disease.
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